Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Visual Fields Examination and Interpretation_Walsh_2011

.pdf
Скачиваний:
2
Добавлен:
28.03.2026
Размер:
15.35 Mб
Скачать

176

Visual Fields

52.

Wall M. Motion perimetry in optic neuropathies. Perimetry Update 1994/1995.

 

Amsterdam: Kugler; 1995:111–118.

53.

Wall M, Jennisch CJ, Munden PM. Motion perimetry identifies nerve fiber bundlelike

 

defects in ocular hypertension. Arch Ophthalmol. 1997;115:26–33.

54.

De Bruyn B, Orban GA. Human velocity and direction discrimination measured with

 

random dot patterns. Vision Res. 1988;28:1323–1335.

55.

Drum B, Severns M, O’Leary D, et al. Selective loss of pattern discrimination in early

 

glaucoma. Appl Optics. 1989;28:1135–1144.

56.

Nautaitis NJ, Stewart WC, Kelly DM, et al. Pattern discrimination perimetry in patients

,

with glaucoma and ocular hypertension. Am J Ophthalmol. 1992;114:297–301.

57.

Yu TC, Falcao-Reis F, Spileers W, Arden GB. Peripheral color contrast: a new screening

 

test for preglaucomatous visual loss. Invest Ophthalmol Vis Sci. 1991;32:2779–2789.

58.

Heijl A. Improved test algorithms for automated perimetry. In: Krieglstein GK, ed.

 

Glaucoma Update V. Amsterdam: Kaden Verlag; 1995:168–173.

59.

Zulauf M, Fehlmann P, Flammer J. Efficiency of the standard Octopus bracketing

 

procedure compared to that of the “dynamic strategy” of Weber. In: Mills RP, Wall W,

 

eds. Perimetry Update 1994/95. Amsterdam: Kugler; 1994:263–264.

60.

Kelman SE, Perell HE, Autrechy LD, Scott RJ. A neural network can differentiate

 

glaucoma and optic neuropathy visual fields through pattern recognition. In: Mills RP,

 

Heijl A, eds. Perimetry Update 1990/91. Amsterdam: Kugler; 1991:287–290.

61.

Giangiacomo A, Garway-Heath D, Caprioli J. Diagnosing glaucoma progression:

 

current practice and promising technologies. Curr Opin Ophthalmol. 2006;17:

 

153–162.

62.

Heijl A. Improving visual field interpretation in glaucoma management: the importance

 

of and the tools to separate between diffuse, homogenous, and localized visual field

 

loss. Invest Ophthalmol Vis Sci. 1995;36:S389.

63.

McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. Modelling sensitivity loss in low

 

tension glaucoma. Invest Ophthalmol Vis Sci. 1994;35:2183.

64.

Poinoosawmy D, McNaught AI, Fitzke FW, Hitchings RA. Location of early field

 

deterioration in glaucoma suspects. In: Mills RP, Wall W, eds. Perimetry Update

 

1994/95. Amsterdam: Kugler; 1994:289–297.

65.

Weber J, Krieglstein GK. Graphical analysis of topographical trends (GATT) in

 

automated perimetry. Int Ophthalmol. 1989;13:351–356.

66.

Fitzke FW, Crabb DP, McNaught AI, et al. Image processing of computerised visual

 

field data. Br J Ophthalmol. 1995;79:207–212.

5

Inherited or Congenital Optic Nerve Diseases

PETER A. QUIROS, MD, CARLOS FILIPE CHICANI, MD, PHD, AND ALFREDO A. SADUN, MD, PHD

5-1 INTRODUCTION

In this chapter, we discuss inherited/congenital optic nerve diseases and their related visual fields defects. It is important for the ophthalmologist to establish, on the basis of the visual fields defect whether the optic nerve is involved and, if so, whether this is at the level of the optic disc or further back. In addition, the visual fields defect can help establish whether the etiology is acquired or congenital. If the former is the case, then the visual fields defect may reveal an insult that is rapidly progressive and hence requires immediate and aggressive management. The diseases are divided into the categories of congenital optic disc anomalies and heredodegenerative optic atrophies.

5-2 CONGENITAL OPTIC DISC ANOMALIES

Congenital optic disc anomalies include aplasias, dysplasias (hyperplasia and hypoplasia), optic nerve colobomas and pits, anomalous disc elevations: pseudopapilledema with or without hyaline bodies (drusen), and tilted disc and crescents.

5-2-1 Aplasias and Dysplasias. Absence of the optic disc (aplasia) is extremely rare and only a few case reports have been published in the literature.

Optic disc size varies and may be larger (hyperplasia) or smaller (hypoplasia) than normal. Hyperplasia is much less common than hypoplasia and is usually related to ametropias.

177

,

178 Visual Fields

Optic nerve hypoplasia (ONH) may be unilateral or bilateral and isolated or associated with different syndromes. It may be associated with good or poor visual prognosis. It is the most common congenital optic disc anomaly encountered in pediatric ophthalmic practice.1,2

When the nerve head is slightly or segmentally reduced, especially in the presence of normal visual acuity, the diagnosis is based on comparison of disc photographs or calculation of the ratio of the disc center-to-fovea distance to disc diameter. Usually this ratio is increased in hypoplasia and, if higher than 3.0, is almost diagnostic.3 Sometimes the hypoplastic disc is surrounded by a ring of sclera and a ring of hyperpigmentation, described as “double-ring sign”1,2 (Figure 5-1).

Maternal diabetes and use of teratogenic agents such as phenytoin, alcohol, quinine, and cocaine may be associated with ONH. In particular, maternal diabetes is most often associated with segmental ONH of the superior portion of the nerve head.4

Septo-optic dysplasia (de Morsier syndrome) may be recognized by the triad of short stature, nystagmus, and optic disc hypoplasia. It may be also associated with neonatal hypotonia, seizures, prolonged hyperbilirubinemia, hormone deficiencies (antidiuretic, corticotrophin, and growth), and mental retardation. Neuroimaging demonstrates a single anterior ventricle without a midline partition, and the septum pelucidum is absent.5,6

Field defects with ONH are variable and may include the following:

1.Central depression. This corresponds to decreased visual sensitivity in the area near fixation subserved by the papillomacular fibers that may be selectively involved.

2.Nasal wedges. This pattern of field defect has its apex pointing toward the physiologic blind spot and involves ganglion cell axons from the temporal retina.

Figure 5-1. Optic nerve hypoplasia (note the double-ring sign).

 

Inherited or Congenital Optic Nerve Diseases

179

3.

Temporal wedges. This pattern of field defect has its apex pointing toward

 

the physiologic blind spot and involves ganglion cell axons from the nasal

 

retina.

 

4.

Hemianopias. This visual field defect involves the field to either the left or

 

right of the point of fixation but does not cross and hence respects the vertical

 

midline.

 

5.

“Altitudinal” defects. These defects involve the field above or below the

 

point of fixation but do not cross the horizontal midline, at least not initially.

 

Altitudinal defects may involve or spare fixation, depending on the underlying

,

pathology.

 

6.

Generalized constriction. This usually represents an end point of arcuate

 

scotomas that connect, top and bottom, and then expand such that only the

 

central field is spared.1,2,7-9

 

Figure 5-2 shows a central scotoma in a patient with ONH.

Pediatric patients with unilateral or segmental ONH and with normal growth and development should undergo regular ophthalmic and pediatric examinations. Those with bilateral ONH should undergo neuroimaging (magnetic resonance imaging [MRI]) and endocrine evaluation. ONH discovered in neurologically intact adults requires no further workup.8

Figure 5-2. Central scotoma in a patient with optic nerve hypoplasia.

5-2-2 Optic Nerve Colobomas and Pits. Colobomas or pits are congenital malformations that enlarge or distort the nerve head circumference and shape. In most cases, the enlarged peripapillary area is irregularly pigmented with the presence of anomalous vessels. Colobomas are usually unilateral and sporadic.10

The morning glory anomaly is an enlarged, relatively round disc filled with retained embriogenic glial and vascular remnants (Figure 5-3). It often projects forward as a funnel and can be surrounded by an elevated annulus of chorioretinal pigment. When associated with congenital forebrain anomalies, including basal

180 Visual Fields

,

Figure 5-3. Morning glory syndrome.

Figure 5-4. Optic disc pit.

encephaloceles (spheno-orbital, transsphenoidal, or frontoethmoidal), it is termed “morning glory syndrome.” The majority of patients with this syndrome have marked visual loss and amblyopia.11

Patients with congenital disc malformations may complain of transient obscurations of vision, lasting seconds to minutes, but the mechanism of the disturbance is not known.10 Pits of the optic disc are intrapapillary pearly gray slits containing pale glial material (Figure 5-4). They are usually located within the scleral rim of the disc margin and can extend for up to one third of a disc diameter. The disc border is usually distorted, and mild pigment epithelial

Inherited or Congenital Optic Nerve Diseases

181

changes may be present. Pits are usually unilateral and temporally located. There is a positive association with serous detachment of the macula in up to 50% of the cases.12,13

Visual field changes include the following:

1.

Arcuate bundle scotoma. This is actually a mild form of an altitudinal defect.

 

It does not involve fixation but rather the areas just peripheral to it.

2.

Fuchs colobomata. These are usually stable and in the form of dense nerve

,

fiber bundle defects that extend from the blind spot, toward fixation in the

 

papillomacular area (cecocentral scotoma).14

5-2-3 Anomalous Disc Elevations: Pseudopapilledema With or Without Hyaline Bodies (Drusen). Pseudopapilledema are congenitally elevated discs that may present with or without hyaline bodies. Disc hyaline bodies are acellular laminated concretions of unknown origin, often partially calcified. They are possibly related to the accumulation of axoplasmic derivatives from degenerating retinal nerve fibers, in which orthograde axoplasmic flow has been obliterated due to an abnormally narrow scleral canal. These hyaline bodies slowly become visible, as they enlarge toward the disc surface and margin; the overlying retinal nerve fibers also become progressively thinner. Usually they become visible in the early teens. They are usually inherited as autosomal dominant trait. They present in two thirds of cases bilaterally and are not necessarily symmetric. When there is uncertainty between true edema and pseudopapilledema, examination of family members may be helpful.15-17 Hyaline bodies may become symptomatic by insidious visual field loss or spontaneous hemorrhage.18

Visual field defects are usually in the form of:

1.Blind spot enlargement, reflecting absence of functioning photoreceptors mechanically disrupted by the expanding adjacent ONH.

2.Arcuate, which is actually a mild form of an altitudinal defect. It does not involve fixation but rather the areas just peripheral to it.

3.Other nerve fiber bundle patterns, such as altitudinal or nasal step.

4.Other less commonly irregular peripheral constriction that may occur. Normally, these defects progress slowly, with a predilection for involvement of the inferior nasal quadrant.19

Drusen are not an uncommon condition and may be seen in up to 2% of patients.15 Figure 5-5 shows optic disc drusen, and Figure 5-6 shows a central visual field defect (blind spot enlargement) in optic disc drusen.

5-2-4 Tilted Disc and Crescents. Tilted discs usually present with depigmented peripapillary crescents. The most common variety of crescent is that located inferiorly (Fuchs colobomata), usually with inferonasal retinal quadrant involvement and superior temporal field defect without respect for either vertical or horizontal.20, 21 In bilateral cases, visual field shows bitemporal hemianopia, which does not respect the vertical meridian.22

182 Visual Fields

,

Figure 5-5. Optic disc drusen.

Figure 5-6. Central visual field defect (blind spot enlargement) in optic disc drusen.

5-3 HEREDODEGENERATIVE OPTIC ATROPHIES

Heredodegenerative inherited optic neuropathies fall under the rubric of metabolic optic neuropathies. Metabolic optic neuropathies share many common pathophysiologic and clinical characteristics. Most metabolic optic neuropathies involve derangements that affect mitochondria and oxidative phosphorylation. Common hereditary optic neuropathies include Leber’s hereditary optic neuropathy (LHON), dominant optic atrophy (DOA), and congenital recessive optic atrophy (ROA). Like most acquired metabolic optic neuropathies, inherited optic neuropathies all involve mitochondria function. In all cases, mitochondria are impaired either by mutations of their own DNA (mtDNA) or by mutations of nuclear DNA involved in the transcription of mitochondrial proteins or substrates.

The presentation is usually symmetric visual loss with dyschromatopsia and central or cecocentral visual field defects, which involve the optic disc and

,

Inherited or Congenital Optic Nerve Diseases

183

papillomacular fibers. This archetypical set of clinical signs reflects the fact that in metabolic optic neuropathies, there is a strong predilection for the papillomacular bundle (PMB). Prompt recognition of the characteristic elements from history and physical examinations often precludes unnecessary patient laboratory evaluation.

5-3-1 Leber’s Hereditary Optic Neuropathy. LHON is a maternally inherited disease associated with point mutations in mtDNA, and it is now considered the most prevalent mitochondrial disorder.

LHON typically manifests as a subacute central loss of vision that affects predominantly young adult males. The age of onset is usually between 15 and 35 years. Almost invariably, the second eye is affected, within weeks to months. LHON is usually due to one of three pathogenic mtDNA point mutations. These mutations affect nucleotide positions 11778, 3460, and 14484, respectively, in the ND4, ND1, and ND6 subunit genes of complex I, which is integral for oxidative phosphorylation in mitochondria. It is hypothesized that the respiratory chain dysfunction leads to energy depletion and reactive oxygen species (ROS) accumulation, which in turn produce axoplasmic stasis and swelling, thereby blocking ganglion cell function and causing loss of vision. In LHON, the pathologic mutation may either be homoplasmic (involving all the mitochondria) or heteroplasmic (involving only a fraction of the mitochondria). Most heteroplasmic pedigrees have much lower penetrance but, surprisingly, the disease is not milder in form. Even with homoplasmic families, penetrance is highly variable. The rate of penetrance varies with the mutation and pedigree, although it is always greater in males. Hence, in a typical family with the 11778 mtDNA mutation, 8-10% of the women and 40-50% of the men may experience devastating and sudden visual loss in young adulthood.23-28

In LHON, fundus changes, such as microangiopathy and nerve fiber layer swelling, have been described to immediately precede or accompany the onset of visual loss. This process, although usually bilateral, occurs asynchronously over the course of several weeks to months and eventually evolves to severe optic atrophy and irreversible impairments of vision.

The acute stage of LHON usually lasts a few weeks. The affected eye characteristically demonstrates an early dropout of the PMB; an edematous appearance of the rest of the nerve fiber layer, especially in the arcuate bundles; and enlarged or telangiectatic and tortuous peripapillary vessels (microangiopathy). There is absence of leakage from the optic disc or peripapillary region on fluorescein angiography.29-34 Figure 5-7 shows classical funduscopic findings seen in the acute phase of LHON.

Clinical examination reveals decreased visual acuity and dyschromatopsia. Visual field examination usually shows cecocentral scotoma. This defect extends from the physiologic “blind spot” to involve fixation. Although a central scotoma may also encompass the blind spot, a cecocentral scotoma is smaller and typically dumbbell shaped. Later, with progression of the disease, the central scotoma becomes much larger and absolute.29-33 Figure 5-8 shows a dense central visual field defect in a patient with LHON.

184 Visual Fields

,

A

B

Figure 5-7. Right and left eyes of a patient with Leber’s hereditary optic neuropathy. Fundus photographs of both eyes demonstrate hyperemic optic nerve heads, with dilated tortuous vessels, and swollen retinal nerve fiber layer (pseudoedema of the optic disc). Note also the telangectatic vessels.

There are a few reports of spontaneous recovery, especially with the 14484/ND6 mutation (up to 60% of cases) and in younger patients. Most often, the visual loss progressing to total optic atrophy over time stabilizes within 1 year, with the early development of temporal optic atrophy.

There is currently no clinical evidence for an efficacious treatment to reverse vision loss in LHON. Theoretical considerations have led to the use of several agents involved with mitochondrial energy production and with antioxidant capabilities, such as coenzyme Q10 (or its analogues), succinate, L-carnitine, vitamins K1, K3, C, and B12, folate, and thiamine. It remains unlikely that any of these agents alone or in combination will prove consistently useful in the treatment of acute visual loss in LHON or in the prophylactic therapy in asymptomatic family members at risk.23,27,28,31

However, it is prudent to recommend the avoidance of agents that might induce oxidative stress or impair mitochondrial energy production. Most specifically, it is imperative to avoid exposure to smoke and alcohol because these environmental factors can trigger the loss of vision in susceptible individuals.34

Inherited or Congenital Optic Nerve Diseases

185

,

Figure 5-8. Dense central visual field defect in patient with Leber’s hereditary optic neuropathy.

5-3-2 Dominant Optic Atrophy. DOA, or Kjer’s optic neuropathy, is one of the most common forms of hereditary optic atrophies. Presentation usually occurs at latency age (7-10 years old). It often presents with an imperceptible onset and a slowly progressive course and results in mild to moderate visual impairment (20/40 to 20/400). The inheritance of DOA is autosomal dominant. Despite the variability in expression, the penetrance is actually very high. DOA presents as mild, bilateral, sometimes asymmetric loss of visual acuity. On examination, there is temporal